Cannabis and Cancer – Studies Suggesting That Cannabis May Help in Cancer Treatment

Much of the debate associated with the legal use of cannabis as medicine is the “perceived” lack of clinical data. What you will find here are the studies that support the potential for cannabis as a cure for cancer. The administration of this cancer medicine is varied and not limited to smoking /vaporising. Keeping an open mind, coupled with  a true desire to achieve wellness – you will find the ultimate healing that exists in natures’s most powerful plant -Cannabis.
  1. Published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid. The conclusion made from this study was the determination that Tetrahydrocannabinol (THC) and other cannabinoids prevent the growth of tumours. Pioneering the study of cannabinoid treatment, this was among the first of clinical studies aimed at proving the potential for  cannabinoid antitumoral action. The method used in delivering the Cannabinoid medicine was safe and patients obtained benefits without experiencing psychoactive effects. THC was discovered to reduce the number of tumour cells in 2 out of 9 patients involved in the study.
  2. Published in The Journal of Neuroscience another study observed and acknowledged the biochemical events resulting from acute neuronal damages as well as in slowly progressive, neurodegenerative diseases. Conducting a magnetic resonance imaging study, THC was analysed and found that it had the ability to reduce neuronal injury in rats. This discovery offered clinical evidence of the cannabinoid system in its mission to serve and protect the brain against neurodegeneration.
  3. Published in The Journal of Pharmacology And Experimental Therapeutics this study with the knowledge already that cannabinoids possess antitumor properties, continued to analyse the effectiveness of Cannabidiol (CBD) on human glioma cells or “brain cancer cells”.  The addition of CBD in the study created a respectable drop in the viability of the glioma cells. This study concluded that cannabidiol produced anti tumour activity of a significantly large scale.
  4. Published in the Journal of Molecular Cancer Therapeutics, this study revealed the resistance brain tumours have to current anticancer treatments.  It also went on to discuss how important it was for the medical industry to be open to the potential in alternative therapeutic strategies – particularly in the cure for brain cancer.  This study demonstrated the reversal of tumour activity in Glioblastoma multiforme.
5.A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined the inhibition of human breast cancer cell proliferation and invasion with the use of cannabidiol (CBD). They also demonstrated how CBD dramatically reduces tumour mass.
6.A study published in The Journal of Pharmacology and Experimental Therapeutics concluded that the combination of both THC and CBD dramatically reduced cell growth in breast cancer patients. They confirmed the effectiveness of these compounds.
7. A study published in the Journal of Molecular Cancer reported that THC reduced the size and number of tumours. This determination was that cannabinoids do in fact inhibit cancer cell proliferation. Cannabinoids also induce cancer cell apoptosis and impair tumour angiogenesis. This strong evidence positively promotes cannabinoid based therapies for those patients diagnosed with breast cancer.
8. A study published in the Proceedings of the National Academy of Sciences of the USA (PNAS) also determined cannabinoids and their inhibition of human breast cancer cell proliferation.
9. A study published in the Journal Oncogene, by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor. THC also induces lung cancer cell migration and followed up by stating that THC needed further exploration for it has the potential to control both the growth and metastasis of certain lung cancers.

10. A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany revealed that cannabinoids inhibit cancer cell invasion. They were able to confirm these effects in primary tumour cells from a human lung cancer patient. Conclusion from this study was that cannabinoids decrease cancer cell invasiveness.

11. A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated lung cancer cells and the role cannabinoid receptors play in treating lung cancer. They determined its effectiveness suggesting its use in the treatment of lung cancer.

12. A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells with activation of cannabinoid receptors.

13. A study published in the US National Library of Medicine outlined multiple studies which proved cannabis being effective in treating prostate cancer.

14. Another study published by the US National Library of Medicine discussed the necessity for clinical testing of CBD against prostate carcinoma since cannabinoid receptor activation induces prostate carcinoma cell apoptosis. Again this study concluded that CBD cannabidiol significantly inhibited cancer cell viability.

15. A study published in the journal Molecular Pharmacology recently presented evidence that cannabinoids induce growth inhibition and apoptosis in mantle cell lymphoma. This study was supported by grants from The Swedish Research Council, Swedish Cancer Society, and the Cancer Society in Stockholm.

16. A study published in the International Journal of Cancer revealed that cannabinoids exert antiproliferative and proapoptotic effects in many different types of cancer alongside that of mantle cell lymphoma.

17. A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University found that cannabinoids induce apoptosis in leukemia cells.

18. A study published by the US National Library of Medicine provided evidence showing how cannabinoids are potent inhibitors of cellular respiration. Also that cannabinoids are toxic to highly malignant oral Tumours.
19. A study published by the US National Library of Medicine discovered the effectiveness of THC in reducing the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) also preventing and reducing the growth.
20. A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results provided evidence of cannabinoid administration induced apoptosis. Alongside the evidence showed the reduction in the growth of tumour cells, and the prevention of pancreatic tumour cells spreading.

How I fought cancer with natural remedies

Published by The Herald Sun

Summary: In July 2014 Carolyn Foord was diagnosed with breast cancer. She […]

Read More

Comments Off

Medical Cannabis Bill Passes Parliament

Published by Huffington Post

CANBERRA — Australia has passed a bill to allow cultivation of medical […]

Read More

Comments Off

Cannabis helps my epileptic son

Originally Published by Huffington Post
Written by Catherine Jacobson Neuroscientist, director of clinical research at Tilray

 

Summary […]

Read More

Comments Off

Gold Coast couple giving 13 year boy cannabis for Epilepsy

Published by Yahoo News

Reveals the story of an Epileptic 13-year old boy from Gold […]

Read More

Comments Off